Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence, Hepatology, vol.29, issue.Suppl, pp.1333-1342, 2013. ,
DOI : 10.1111/j.1478-3231.2008.01927.x
Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir, Liver International, vol.3, issue.Suppl 1, pp.60-68, 2014. ,
DOI : 10.1056/NEJMoa1208809
Treatment as prevention and cure towards global eradication of hepatitis C virus, Trends in Microbiology, vol.21, issue.12, pp.625-633, 2013. ,
DOI : 10.1016/j.tim.2013.09.008
The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease, Top Antivir Med, vol.21, pp.15-19, 2013. ,
Role of the specific T-cell response for clearance and control of hepatitis C virus, Journal of Viral Hepatitis, vol.6, issue.s1, pp.36-40, 1999. ,
DOI : 10.1016/S0140-6736(95)91992-9
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells, Nature Medicine, vol.163, issue.7, pp.859-868, 2013. ,
DOI : 10.1172/JCI40594
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proceedings of the National Academy of Sciences, vol.43, issue.6, pp.6025-6030, 2007. ,
DOI : 10.1002/hep.21191
URL : https://hal.archives-ouvertes.fr/inserm-00395910
Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion, The Journal of Infectious Diseases, vol.205, issue.5, pp.763-771, 2012. ,
DOI : 10.1093/infdis/jir835
Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses, Hepatology, vol.3, issue.Suppl 7, pp.2140-2151, 2014. ,
DOI : 10.1186/1753-6561-3-s7-s34
A prophylactic hepatitis C virus vaccine: A distant peak still worth climbing, Journal of Hepatology, vol.61, issue.1, pp.34-44, 2014. ,
DOI : 10.1016/j.jhep.2014.09.009
URL : http://doi.org/10.1016/j.jhep.2014.09.009
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man, Science Translational Medicine, vol.79, issue.2, pp.115-116, 2012. ,
DOI : 10.1002/cyto.a.21015
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627207
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory, Science Translational Medicine, vol.31, issue.2, pp.261-153, 2014. ,
DOI : 10.1038/nbt.2593
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669853
The role of neutralizing antibodies in hepatitis C virus infection, Journal of General Virology, vol.93, issue.1, pp.1-19, 2011. ,
DOI : 10.1099/vir.0.035956-0
The past, present and future of neutralizing antibodies for hepatitis C virus, Antiviral Research, vol.105, pp.100-111, 2014. ,
DOI : 10.1016/j.antiviral.2014.02.013
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses, Immunological Reviews, vol.436, issue.Suppl., pp.99-108, 2011. ,
DOI : 10.4049/jimmunol.169.6.3447
Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus, The Journal of Infectious Diseases, vol.204, issue.8, pp.1186-1190, 2011. ,
DOI : 10.1093/infdis/jir511
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203383
Vaccination of chimpanzees against infection by the hepatitis C virus., Proceedings of the National Academy of Sciences, vol.91, issue.4, pp.1294-1298, 1994. ,
DOI : 10.1073/pnas.91.4.1294
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults, Vaccine, vol.28, issue.38, pp.6367-6373, 2010. ,
DOI : 10.1016/j.vaccine.2010.06.084
Hepatitis C Virus Glycoprotein Complex Localization in the Endoplasmic Reticulum Involves a Determinant for Retention and Not Retrieval, Journal of Biological Chemistry, vol.269, issue.48, pp.32088-32095, 1998. ,
DOI : 10.1083/jcb.122.6.1185
Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells, Virology, vol.188, issue.2, pp.819-830, 1992. ,
DOI : 10.1016/0042-6822(92)90537-Y
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C, Hepatology, vol.31, issue.5, pp.1289-1296, 2003. ,
DOI : 10.1053/jhep.2003.50474
Immunogenicity and Tolerability of Intradermal Administration of an HCV E1-Based Vaccine Candidate in Healthy Volunteers and Patients with Resolved or Ongoing Chronic HCV Infection, Human Vaccines, vol.1, issue.2, pp.61-65, 2005. ,
DOI : 10.4161/hv.1.2.1554
Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene, Molecular Immunology, vol.43, issue.12, pp.1941-1952, 2006. ,
DOI : 10.1016/j.molimm.2005.11.018
Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies, New Biotechnology, vol.25, issue.4, pp.226-234, 2009. ,
DOI : 10.1016/j.nbt.2009.01.001
URL : https://hal.archives-ouvertes.fr/inserm-00380276
Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine, Hepatology, vol.8, issue.Suppl 1, pp.1303-1313, 2013. ,
DOI : 10.1016/S1473-3099(08)70126-9
URL : https://hal.archives-ouvertes.fr/inserm-00812948
Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes, Journal of Virology, vol.75, issue.5, pp.2130-2141, 2015. ,
DOI : 10.1128/JVI.75.5.2130-2141.2001
Chimeric hepatitis B virus (HBV)/hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine, Vaccine, vol.33, issue.8, pp.973-976, 2015. ,
DOI : 10.1016/j.vaccine.2015.01.007
URL : https://hal.archives-ouvertes.fr/inserm-01575077
Hepatitis C Virus-Like Particle Morphogenesis, Journal of Virology, vol.76, issue.8, pp.4073-4079, 2002. ,
DOI : 10.1128/JVI.76.8.4073-4079.2002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC136094
Biosynthesis and biochemical properties of the hepatitis C virus core protein, J Virol, vol.68, pp.3631-3641, 1994. ,
Charged Residues in the Transmembrane Domains of Hepatitis C Virus Glycoproteins Play a Major Role in the Processing, Subcellular Localization, and Assembly of These Envelope Proteins, Journal of Virology, vol.74, issue.8, pp.3623-3633, 2000. ,
DOI : 10.1128/JVI.74.8.3623-3633.2000
URL : https://hal.archives-ouvertes.fr/hal-00313712
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nature Medicine, vol.37, issue.7, pp.791-796, 2005. ,
DOI : 10.1002/jmv.10297
Robust Hepatitis C Genotype 3a Cell Culture Releasing Adapted Intergenotypic 3a/2a (S52/JFH1) Viruses, Gastroenterology, vol.133, issue.5, pp.1614-1626, 2007. ,
DOI : 10.1053/j.gastro.2007.08.005
Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization, Proceedings of the National Academy of Sciences, vol.165, issue.3, pp.997-1002, 2008. ,
DOI : 10.1093/infdis/165.3.438
Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs, Hepatology, vol.46, issue.2, pp.364-377, 2009. ,
DOI : 10.1002/hep.21994
Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt, Proceedings of the National Academy of Sciences, vol.82, issue.5-6, pp.14757-14762, 2010. ,
DOI : 10.1053/jhep.2001.20797
Human Monoclonal Antibody to Hepatitis C Virus E1 Glycoprotein That Blocks Virus Attachment and Viral Infectivity, Journal of Virology, vol.78, issue.13, pp.7257-7263, 2004. ,
DOI : 10.1128/JVI.78.13.7257-7263.2004
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC421663
Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies, Journal of Virology, vol.82, issue.12, pp.6061-6066, 2008. ,
DOI : 10.1128/JVI.02475-07
Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus, Journal of Virology, vol.82, issue.2, pp.966-973, 2008. ,
DOI : 10.1128/JVI.01872-07
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus, Proceedings of the National Academy of Sciences, vol.2, issue.4, pp.6205-6210, 2012. ,
DOI : 10.1162/153535003322750637
Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins, Gastroenterology, vol.139, issue.3, pp.965-974, 2010. ,
DOI : 10.1053/j.gastro.2010.05.077
A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers, Vaccine, vol.22, issue.23-24, pp.3080-3086, 2004. ,
DOI : 10.1016/j.vaccine.2004.02.002
A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques, Science Translational Medicine, vol.71, issue.1, p.21813755, 2011. ,
DOI : 10.1007/978-1-59745-394-3_32
Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa, Hepatology, vol.192, issue.1, pp.8-16, 1996. ,
DOI : 10.1006/bbrc.1993.1462
Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies, The Journal of Infectious Diseases, vol.204, issue.6, pp.837-844, 2011. ,
DOI : 10.1093/infdis/jir423
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies, Vaccine, vol.25, issue.45, pp.7773-7784, 2007. ,
DOI : 10.1016/j.vaccine.2007.08.053
Fine Mapping of Murine Antibody Responses to Immunization with a Novel Soluble Form of Hepatitis C Virus Envelope Glycoprotein Complex, Journal of Virology, vol.88, issue.18, pp.10459-10471, 2014. ,
DOI : 10.1128/JVI.01584-14
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster, Journal of Virology, vol.86, issue.21, pp.11558-11566, 2012. ,
DOI : 10.1128/JVI.01776-12
Characterization of the Envelope Glycoproteins Associated with Infectious Hepatitis C Virus, Journal of Virology, vol.84, issue.19, p.20668082, 2010. ,
DOI : 10.1128/JVI.01180-10